Differential effects of PDCD4 depletion on protein synthesis in myoblast and myotubes

BMC Cell Biology

Olasunkanmi A J Adegoke¹  Naomi Maeda¹  Nushaba Islam¹  Dhanshri Kakade¹ 

[1] School of Kinesiology & Health Science and Muscle Health Research Centre, York University, 4700 Keele Street, Toronto, Ontario M3J 1P3, Canada

关键词: Skeletal muscle;    Protein synthesis;    S6K1;    mRNA translation;    PDCD4;   

Others  :  855010
DOI  :  10.1186/1471-2121-15-2

 received in 2013-11-01, accepted in 2014-01-04,  发布年份 2014

【 摘 要 】

Background

Reduced muscle mass is a hallmark of metabolic diseases like diabetes and cancer. The mammalian (mechanistic) target of rapamycin complex 1/S6 kinase 1 (mTORC1/S6K1) pathway is critical to the regulation of muscle protein synthesis and mass but its mechanism of action is not completely understood.

Results

Using L6 myotubes, we characterized the regulation of programmed cell death 4 (PDCD4), a recently described substrate of S6K1. The abundance, but not Ser67 phosphorylation, of PDCD4 was sensitive to amino acid and serum deprivation: values in starved cells were 4.5X of control (P < 0.001). Refeeding had opposite effects. Growth factors, compared to amino acids, appeared more critical in regulating PDCD4 abundance. Furthermore, inhibition of mTORC1 or the proteasome prevented the refeeding-associated decrease in PDCD4 abundance. Amino acid and serum deprivation significantly increased PDCD4 binding to eIF4A (P < 0.05); this was reversed during refeeding. PDCD4 depletion by RNA interference had no significant effect on phenylalanine incorporation into myotube mixed proteins in control cells but further suppressed (30%) this measure in nutrient-deprived cells (P < 0.0005). This was not observed in myoblasts. In starved myotubes, PDCD4 depletion further reduced the association of eIF4G with eIF4E.

Conclusion

Our data suggest that in myotubes, PDCD4 abundance is sensitive to nutritional manipulation in an mTORC1 and proteasome depended manner. Furthermore, the role of PDCD4 in regulating protein synthesis appears dependent on the developmental state of the cell.

【 授权许可】

   
2014 Kakade et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Adegoke OA, Abdullahi A, Tavajohi-Fini P: mTORC1 and the regulation of skeletal muscle anabolism and mass. Appl Physiol Nutr Metab 2012, 37(3):395-406.
• [2]Glass D, Roubenoff R: Recent advances in the biology and therapy of muscle wasting. Ann N Y Acad Sci 2010, 1211(1):25-36.
• [3]Ray BN, Kweon HK, Argetsinger LS, Fingar DC, Andrews PC, Carter-Su C: Research resource: identification of novel growth hormone-regulated phosphorylation sites by quantitative phosphoproteomics. Mol Endocrinol 2012, 26(6):1056-1073.
• [4]Sengupta S, Peterson TR, Sabatini DM: Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 2010, 40(2):310-322.
• [5]Kimball SR, Jefferson LS: Control of translation initiation through integration of signals generated by hormones, nutrients and exercise. J Biol Chem 2010, 285(38):29027-29032. doi: 10.1074/jbc.R110.137208. Epub 2010 Jun 24. Review
• [6]Mieulet V, Roceri M, Espeillac C, Sotiropoulos A, Ohanna M, Oorschot V, Klumperman J, Sandri M, Pende M: S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover. Am J Physiol Cell Physiol 2007, 293(2):C712-C722.
• [7]Ruvinsky I, Meyuhas O: Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 2006, 31(6):342-348.
• [8]Onishi Y, Hashimoto S, Kizaki H: Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene 1998, 215(2):453-459.
• [9]Yoshinaga H, Matsuhashi S, Fujiyama C, Masaki Z: Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody. Pathol Int 1999, 49(12):1067-1077.
• [10]Azzoni L, Zatsepina O, Abebe B, Bennett IM, Kanakaraj P, Perussia B: Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J Immunol 1998, 161(7):3493-3500.
• [11]Allgayer H: Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 2010, 73(3):185-191.
• [12]Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M: S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 2006, 314(5798):467-471.
• [13]Yang HS, Cho MH, Zakowicz H, Hegamyer G, Sonenberg N, Colburn NH: A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 2004, 24(9):3894-3906.
• [14]Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH: The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 2003, 23(1):26-37.
• [15]Lankat-Buttgereit B, Goke R: The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 2009, 101(6):309-317.
• [16]Wei NA, Liu SS, Leung TH, Tam KF, Liao XY, Cheung AN, Chan KK, Ngan HY: Loss of programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer. Mol Cancer 2009, 8:70. BioMed Central Full Text
• [17]Chen Y, Knösel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, Ozaki I, Petersen I: Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 2003, 200(5):640-646.
• [18]Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH: Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2//neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 2004, 23(49):8135-8145.
• [19]Zhang S, Li J, Jiang Y, Xu Y, Qin C: Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells. J Exp Clin Cancer Res 2009, 28:71. BioMed Central Full Text
• [20]Zargar S, Moreira TS, Samimi-Seisan H, Jeganathan S, Kakade D, Islam N, Campbell J, Adegoke OA: Skeletal muscle protein synthesis and the abundance of the mRNA translation initiation repressor PDCD4 are inversely regulated by fasting and refeeding in rats. Am J Physiol Endocrinol Metab 2011, 300(6):E986-E992.
• [21]Shi J, Luo L, Eash J, Ibebunjo C, Glass DJ: The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling. Dev Cell 2011, 21(5):835-847.
• [22]Lankat-Buttgereit B, Lenschen B, Schmidt H, Goke R: The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells. Apoptosis 2008, 13(1):157-164.
• [23]Blommaart EF, Luiken JJ, Blommaart PJ, van Woerkom GM, Meijer AJ: Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J Biol Chem 1995, 270(5):2320-2326.
• [24]Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, Avruch J: Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 1998, 273(23):14484-14494.
• [25]Bolster DR, Jefferson LS, Kimball SR: Regulation of protein synthesis associated with skeletal muscle hypertrophy by insulin-, amino acid- and exercise-induced signalling. Proc Nutr Soc 2004, 63(2):351-356.
• [26]Crozier SJ, Kimball SR, Emmert SW, Anthony JC, Jefferson LS: Oral leucine administration stimulates protein synthesis in rat skeletal muscle. J Nutr 2005, 135(3):376-382.
• [27]Meijer AJ, Dubbelhuis PF: Amino acid signalling and the integration of metabolism. Biochem Biophys Res Commun 2004, 313(2):397-403.
• [28]Rennie MJ, Bohe J, Smith K, Wackerhage H, Greenhaff P: Branched-chain amino acids as fuels and anabolic signals in human muscle. J Nutr 2006, 136(1 Suppl):264S-268S.
• [29]el-Naggar EA, Kanda F, Okuda S, Maeda N, Nishimoto K, Ishihara H, Chihara K: Direct effects of tumor necrosis factor alpha (TNF-alpha) on L6 myotubes. Kobe J Med Sci 2004, 50(1–2):39-46.
• [30]Nobukuni T, Joaquin M, Roccio M, Dann SG, Kim SY, Gulati P, Byfield MP, Backer JM, Natt F, Bos JL, et al.: Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci U S A 2005, 102(40):14238-14243.
• [31]Guertin DA, Sabatini DM: The pharmacology of mTOR inhibition. Sci Signal 2009, 2(67):e24.
• [32]Bitomsky N, Wethkamp N, Marikkannu R, Klempnauer KH: siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression. Oncogene 2008, 27(35):4820-4829.
• [33]Santhanam AN, Baker AR, Hegamyer G, Kirschmann DA, Colburn NH: Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene 2010, 29(27):3921-3932.
• [34]Singh P, Wedeken L, Waters LC, Carr MD, Klempnauer KH: Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation. Oncogene 2011, 30(49):4864-4873.
• [35]Eto K, Goto S, Nakashima W, Ura Y, Abe SI: Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA. Cell Death Differ 2012, 19(4):573-581.
• [36]Wedeken L, Singh P, Klempnauer KH: Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA. J Biol Chem 2011, 286(50):42855-42862.
• [37]Zammit PS, Partridge TA, Yablonka-Reuveni Z: The skeletal muscle satellite cell: the stem cell that came in from the cold. J Histochem Cytochem 2006, 54(11):1177-1191.
• [38]Dhawan J, Rando TA: Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol 2005, 15(12):666-673.
• [39]Kadi F, Ponsot E: The biology of satellite cells and telomeres in human skeletal muscle: effects of aging and physical activity. Scand J Med Sci Sports 2010, 20(1):39-48.
• [40]Gulve EA, Dice JF: Regulation of protein synthesis and degradation in L8 myotubes. Effects of serum, insulin and insulin-like growth factors. Biochem J 1989, 260(2):377-387.